XML 96 R60.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity [Abstract] |
Schedule of Stock by Class | Preferred stock authorized, issued and outstanding was as follows at both December 31, 2024 and 2023:
Series |  | Shares Authorized |  | Shares Issued and Outstanding
Series A preferred stock |  | 27,600,000 |  |  | 24,000,000 |
Series D preferred stock |  | 500,000 |  |  | 500,000 |
Series E preferred stock |  | 32,200 |  |  | 32,200 |
Series F preferred stock |  | 40,000 |  |  | 40,000 |
Series G preferred stock |  | 1,000,000 |  |  | 1,000,000 |
Series A Junior Participating Preferred Stock |  | 10,000,000 |  |  | — |
Not designated |  | 160,827,800 |  |  | — |
Total |  | 200,000,000 |  |  | 25,572,200 |
Components of compensation expense related to stock based compensation | Compensation Expense Related to Stock-Based Compensation The components of compensation expense related to stock-based compensation includes compensation expense related to Phantom Stock-Based Awards and excludes the insignificant compensation expense related to the 2015 Director Stock Plan. Those components were:
| Years Ended December 31,
| 2024 |  | 2023 |  | 2022
| (In millions)
Stock Options and Unit Options | $ | 7 |  |  | $ | 7 |  |  | $ | 7 |
Performance Shares and Performance Units (1) | 87 |  |  | 98 |  |  | 108 |
Restricted Stock Units and Restricted Units | 74 |  |  | 66 |  |  | 69 |
Total compensation expense | $ | 168 |  |  | $ | 171 |  |  | $ | 184 |
Income tax benefit | $ | 35 |  |  | $ | 36 |  |  | $ | 39 |
__________________ (1)The Company may further adjust the number of Performance Shares and Performance Units it expects to vest, and the related compensation expense, if management changes its estimate of the most likely final performance factor.
Total unrecognized compensation expense related to stock based compensation and the expected weighted average period over which the expenses will be recognized | The following table presents the total unrecognized compensation expense related to stock-based compensation and the expected weighted average period over which these expenses will be recognized at:
| December 31, 2024
| Expense |  | Weighted Average Period
| (In millions) |  | (Years)
Stock Options | $ | 2 |  |  | 1.79
Performance Shares | $ | 25 |  |  | 1.69
Restricted Stock Units | $ | 35 |  |  | 1.94
Activity related to Stock Options | Stock Option Activity A summary of the activity related to Stock Options was as follows:
| Shares Under Option |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value (1)
|  |  |  |  | (Years) |  | (In millions)
Outstanding at January 1, 2024 | 3,500,006 |  |  | $ | 52.04 |  |  | 5.21 |  | $ | 53 |
Granted | 384,796 |  |  | $ | 69.16 |  |  |  |  |
Exercised | (855,101) |  |  | $ | 46.23 |  |  |  |  |
Expired (2) | (12,033) |  |  | $ | 45.15 |  |  |  |  |
Forfeited (3) | (23,297) |  |  | $ | 69.97 |  |  |  |  |
Outstanding at December 31, 2024 | 2,994,371 |  |  | $ | 55.79 |  |  | 5.51 |  | $ | 78 |
Vested and expected to vest at December 31, 2024 | 2,987,964 |  |  | $ | 55.76 |  |  | 5.50 |  | $ | 78 |
Exercisable at December 31, 2024 | 2,247,683 |  |  | $ | 51.07 |  |  | 4.52 |  | $ | 69 |
__________________ (1)The intrinsic value of each Stock Option is the closing price on a particular date less the exercise price of the Stock Option, so long as the difference is greater than zero. The aggregate intrinsic value of all outstanding Stock Options is computed using the closing Share price on December 31, 2024 of $81.88 and December 31, 2023 of $66.13, as applicable. (2)Expired options were exercisable, but unexercised, as of their expiration date. (3)Forfeited awards were either (a) unvested or unexercisable at the end of the awardholder’s employment, where the awardholder did not meet the criteria for post-employment award continuation; or (b) held by awardholders the Company terminated from employment for cause as defined in the terms of the awards. The following table presents a summary of Stock Option exercise activity:
|  | Years Ended December 31,
|  | 2024 |  | 2023 |  | 2022
|  | (In millions)
Total intrinsic value of stock options exercised |  | $ | 25 |  |  | $ | 6 |  |  | $ | 40 |
Cash received from exercise of stock options |  | $ | 40 |  |  | $ | 11 |  |  | $ | 48 |
Income tax benefit realized from stock options exercised |  | $ | 5 |  |  | $ | 1 |  |  | $ | 8 |
Weighted average assumptions used to determine the fair value of Stock Options issued | The following table presents the weighted average assumptions, with the exception of risk-free rate (which is expressed as a range), that the model uses to determine the fair value of unexercised Stock Options:
|  | Years Ended December 31,
|  | 2024 |  | 2023 |  | 2022
Dividend yield |  | 3.01% |  | 2.79% |  | 2.78%
Risk-free rate of return |  | 5.03% - 4.22% |  | 5.02% - 3.47% |  | 1.17% - 1.97%
Expected volatility |  | 26.36% |  | 25.73% |  | 26.67%
Exercise multiple |  | 1.45 |  | 1.45 |  | 1.45
Post-vesting termination rate |  | 3.33% |  | 3.47% |  | 3.58%
Contractual term (years) |  | 10 |  | 10 |  | 10
Expected life (years) |  | 6 |  | 6 |  | 6
Weighted average exercise price of stock options granted |  | $69.16 |  | $71.73 |  | $68.96
Weighted average fair value of stock options granted |  | $17.13 |  | $17.56 |  | $15.18
Performance Share and Restricted Stock Unit Activity | Performance Share and Restricted Stock Unit Activity The following table presents a summary of Performance Share and Restricted Stock Unit activity:
| Performance Shares |  | Restricted Stock Units
| Shares |  | Weighted Average Fair Value (1) |  | Units |  | Weighted Average Fair Value (1)
Outstanding at January 1, 2024 | 2,913,498 |  |  | $ | 59.65 |  |  | 1,849,617 |  |  | $ | 61.68 |
Granted | 1,007,673 |  |  | $ | 62.87 |  |  | 1,014,399 |  |  | $ | 63.44 |
Forfeited (2) | (118,051) |  |  | $ | 63.73 |  |  | (144,583) |  |  | $ | 63.42 |
Payable (3) | (1,048,303) |  |  | $ | 51.37 |  |  | (907,842) |  |  | $ | 59.29 |
Outstanding at December 31, 2024 | 2,754,817 |  |  | $ | 63.80 |  |  | 1,811,591 |  |  | $ | 63.72 |
Vested and expected to vest at December 31, 2024 | 2,717,853 |  |  | $ | 63.80 |  |  | 1,779,539 |  |  | $ | 63.72 |
__________________ (1)Values for awards outstanding at January 1, 2024, represent weighted average number of awards multiplied by their fair value per Share at December 31, 2023. Otherwise, all values represent weighted average of number of awards multiplied by the fair value per Share at December 31, 2024. Fair value of Performance Shares and Restricted Stock Units on December 31, 2024 was equal to Grant Date fair value. (2)Forfeited awards were either (a) unvested or unexercisable at the end of the awardholder’s employment, where the awardholder did not meet the criteria for post-employment award continuation; or (b) held by awardholders the Company terminated from employment for cause as defined in the terms of the awards. (3)Includes both Shares paid and Deferred Shares.
Liability Award Unit Activity | Liability Award Activity The following table presents a summary of Liability Awards activity:
| Unit Options |  | Performance Units |  | Restricted Units
Outstanding at January 1, 2024 | 39,152 |  |  | 339,541 |  |  | 389,491 |
Granted | 14,699 |  |  | 138,397 |  |  | 224,743 |
Exercised | (9,202) |  |  | — |  |  | — |
Expired (1) | (3,911) |  |  | — |  |  | — |
Forfeited (2) | — |  |  | (12,829) |  |  | (19,812) |
Paid | — |  |  | (118,848) |  |  | (195,472) |
Outstanding at December 31, 2024 | 40,738 |  |  | 346,261 |  |  | 398,950 |
Vested and expected to vest at December 31, 2024 | 40,173 |  |  | 338,603 |  |  | 390,822 |
__________________ (1)Expired options were exercisable, but unexercised, as of their expiration date. (2)Forfeited awards were either (a) unvested or unexercisable at the end of the awardholder’s employment, where the awardholder did not meet the criteria for post-employment award continuation; or (b) held by awardholders the Company terminated from employment for cause as defined in the terms of the awards.
Schedules of statutory net income, capital and surplus and reserve strengthening by subsidiary | Statutory net income (loss) was as follows:
|  |  |  | Years Ended December 31,
Company |  | State of Domicile |  | 2024 |  | 2023 |  | 2022
|  |  |  | (In millions)
MLIC |  | New York |  | $ | 2,457 |  |  | $ | 3,407 |  |  | $ | 2,737 |
American Life |  | Delaware |  | $ | 365 |  |  | $ | 767 |  |  | $ | 824 |
Metropolitan Tower Life Insurance Company (“MTL”) |  | Nebraska |  | $ | 361 |  |  | $ | 411 |  |  | $ | 232 |
Other |  | Various |  | $ | 65 |  |  | $ | 53 |  |  | $ | 91 |
Statutory capital and surplus was as follows at:
|  | December 31,
Company |  | 2024 |  | 2023
|  | (In millions)
MLIC |  | $ | 9,787 |  |  | $ | 11,593 |
American Life |  | $ | 7,555 |  |  | $ | 8,272 |
MTL |  | $ | 2,247 |  |  | $ | 2,461 |
Other |  | $ | 347 |  |  | $ | 358 |
Dividend Payment Restrictions | The table below sets forth the dividends permitted to be paid by MetLife, Inc.’s primary insurance subsidiaries without insurance regulatory approval and the actual dividends paid:
|  | 2025 |  | 2024 |  | 2023
Company |  | Permitted Without Approval (1) |  | Paid (2) |  | Paid (2)
|  | (In millions) |
MLIC |  | $ | 2,732 |  |  | $ | 3,476 |  |  |  | $ | 2,471 |  |
American Life |  | $ | 751 |  |  | $ | 1,485 |  |  |  | $ | 1,887 |  |
MTL |  | $ | 358 |  |  | $ | 373 |  |  |  | $ | 189 |  |
__________________ (1)Reflects dividend amounts that may be paid by the end of 2025 without prior regulatory approval. (2)Reflects all amounts paid, including those where regulatory approval was obtained as required.
Components of Accumulated Other Comprehensive Income (Loss) | Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc. was as follows:
| Unrealized Investment Gains (Losses), Net of Related Offsets (1) |  | Deferred Gains (Losses) on Derivatives |  | FPBs Discount Rate Remeasurement Gains (Losses) |  | MRBs Instrument-Specific Credit Risk Remeasurement Gains (Losses) |  | Foreign Currency Translation Adjustments |  | Defined Benefit Plans Adjustment |  | Total
| (In millions)
Balance at December 31, 2021 | $ | 20,919 |  |  | $ | 1,629 |  |  | $ | (18,559) |  |  | $ | 279 |  |  | $ | (5,121) |  |  | $ | (1,598) |  |  | $ | (2,451) |
OCI before reclassifications | (58,093) |  |  | (583) |  |  | 31,755 |  |  | (219) |  |  | (1,625) |  |  | 188 |  |  | (28,577) |
Deferred income tax benefit (expense) | 13,298 |  |  | 89 |  |  | (7,116) |  |  | 47 |  |  | (18) |  |  | (39) |  |  | 6,261 |
AOCI before reclassifications, net of income tax | (23,876) |  |  | 1,135 |  |  | 6,080 |  |  | 107 |  |  | (6,764) |  |  | (1,449) |  |  | (24,767) |
Amounts reclassified from AOCI | 1,607 |  |  | 498 |  |  | — |  |  | — |  |  | — |  |  | 93 |  |  | 2,198 |
Deferred income tax benefit (expense) | (368) |  |  | (76) |  |  | — |  |  | — |  |  | — |  |  | (19) |  |  | (463) |
Amounts reclassified from AOCI, net of income tax | 1,239 |  |  | 422 |  |  | — |  |  | — |  |  | — |  |  | 74 |  |  | 1,735 |
Sale of subsidiaries, net of income tax (2) | (9) |  |  | — |  |  | 35 |  |  | — |  |  | 387 |  |  | (2) |  |  | 411 |
Balance at December 31, 2022 | (22,646) |  |  | 1,557 |  |  | 6,115 |  |  | 107 |  |  | (6,377) |  |  | (1,377) |  |  | (22,621) |
OCI before reclassifications | 7,820 |  |  | (1,106) |  |  | (4,361) |  |  | (102) |  |  | 296 |  |  | (207) |  |  | 2,340 |
Deferred income tax benefit (expense) | (1,666) |  |  | 267 |  |  | 904 |  |  | 22 |  |  | (77) |  |  | 45 |  |  | (505) |
AOCI before reclassifications, net of income tax | (16,492) |  |  | 718 |  |  | 2,658 |  |  | 27 |  |  | (6,158) |  |  | (1,539) |  |  | (20,786) |
Amounts reclassified from AOCI | 2,523 |  |  | (705) |  |  | — |  |  | — |  |  | — |  |  | 119 |  |  | 1,937 |
Deferred income tax benefit (expense) | (537) |  |  | 170 |  |  | — |  |  | — |  |  | — |  |  | (26) |  |  | (393) |
Amounts reclassified from AOCI, net of income tax | 1,986 |  |  | (535) |  |  | — |  |  | — |  |  | — |  |  | 93 |  |  | 1,544 |
Balance at December 31, 2023 | (14,506) |  |  | 183 |  |  | 2,658 |  |  | 27 |  |  | (6,158) |  |  | (1,446) |  |  | (19,242) |
OCI before reclassifications | (7,280) |  |  | (549) |  |  | 4,997 |  |  | (124) |  |  | (858) |  |  | (123) |  |  | (3,937) |
Deferred income tax benefit (expense) | 1,809 |  |  | 144 |  |  | (1,126) |  |  | 26 |  |  | (154) |  |  | 31 |  |  | 730 |
AOCI before reclassifications, net of income tax | (19,977) |  |  | (222) |  |  | 6,529 |  |  | (71) |  |  | (7,170) |  |  | (1,538) |  |  | (22,449) |
Amounts reclassified from AOCI | 752 |  |  | 760 |  |  | — |  |  | — |  |  | — |  |  | 128 |  |  | 1,640 |
Deferred income tax benefit (expense) | (177) |  |  | (168) |  |  | — |  |  | — |  |  | — |  |  | (32) |  |  | (377) |
Amounts reclassified from AOCI, net of income tax | 575 |  |  | 592 |  |  | — |  |  | — |  |  | — |  |  | 96 |  |  | 1,263 |
Balance at December 31, 2024 | $ | (19,402) |  |  | $ | 370 |  |  | $ | 6,529 |  |  | $ | (71) |  |  | $ | (7,170) |  |  | $ | (1,442) |  |  | $ | (21,186) |
__________________ (1)Primarily unrealized gains (losses) on fixed maturity securities. (2)See Note 3 for information on the Company’s business dispositions.
Reclassification out of Accumulated Other Comprehensive Income (Loss) | Information regarding amounts reclassified out of each component of AOCI was as follows:
|  | Years Ended December 31, |  |
|  | 2024 |  | 2023 |  | 2022 |  |
AOCI Components |  | Amounts Reclassified from AOCI |  | Consolidated Statements of Operations Locations
|  | (In millions) |  |
Unrealized investment gains (losses): |  |  |  |  |  |  |  |
Unrealized investment gains (losses) |  | $ | (784) |  |  | $ | (2,620) |  |  | $ | (1,802) |  |  | Net investment gains (losses)
Unrealized investment gains (losses) |  | 2 |  |  | 8 |  |  | 7 |  |  | Net investment income
Unrealized investment gains (losses) |  | 30 |  |  | 89 |  |  | 188 |  |  | Net derivative gains (losses)
Unrealized investment gains (losses), before income tax |  | (752) |  |  | (2,523) |  |  | (1,607) |  |  |
Income tax (expense) benefit |  | 177 |  |  | 537 |  |  | 368 |  |  |
Unrealized investment gains (losses), net of income tax |  | (575) |  |  | (1,986) |  |  | (1,239) |  |  |
Deferred gains (losses) on derivatives — cash flow hedges: |  |  |  |  |  |  |  |
Interest rate derivatives |  | 33 |  |  | 50 |  |  | 59 |  |  | Net investment income
Interest rate derivatives |  | (5) |  |  | 90 |  |  | 41 |  |  | Net investment gains (losses)
Interest rate derivatives |  | — |  |  | — |  |  | 4 |  |  | Other expenses
Foreign currency exchange rate derivatives |  | 4 |  |  | 4 |  |  | 6 |  |  | Net investment income
Foreign currency exchange rate derivatives |  | (794) |  |  | 558 |  |  | (609) |  |  | Net investment gains (losses)
Foreign currency exchange rate derivatives |  | 1 |  |  | 2 |  |  | 1 |  |  | Other expenses
Credit derivatives |  | 1 |  |  | 1 |  |  | — |  |  | Net investment gains (losses)
Gains (losses) on cash flow hedges, before income tax |  | (760) |  |  | 705 |  |  | (498) |  |  |
Income tax (expense) benefit |  | 168 |  |  | (170) |  |  | 76 |  |  |
Gains (losses) on cash flow hedges, net of income tax |  | (592) |  |  | 535 |  |  | (422) |  |  |
Defined benefit plans adjustment: (1) |  |  |  |  |  |  |  |
Amortization of net actuarial gains (losses) |  | (139) |  |  | (130) |  |  | (104) |  |  |
Amortization of prior service (costs) credit |  | 11 |  |  | 11 |  |  | 11 |  |  |
Amortization of defined benefit plan items, before income tax |  | (128) |  |  | (119) |  |  | (93) |  |  |
Income tax (expense) benefit |  | 32 |  |  | 26 |  |  | 19 |  |  |
Amortization of defined benefit plan items, net of income tax |  | (96) |  |  | (93) |  |  | (74) |  |  |
Total reclassifications, net of income tax |  | $ | (1,263) |  |  | $ | (1,544) |  |  | $ | (1,735) |  |  |
__________________ (1)These AOCI components are included in the computation of net periodic benefit costs. See Note 21.
Preferred Stock Dividend Rates | The table below presents the dividend rates of MetLife, Inc.’s preferred stock outstanding at December 31, 2024:
Series |  | Per Annum Dividend Rate
A |  | Three-month CME Term SOFR plus a spread adjustment of 0.26161% + 1.000%, with floor of 4.000%, payable quarterly in March, June, September and December
D |  | 5.875% from issuance date to, but excluding, March 15, 2028, payable semiannually in March and September; three-month CME Term SOFR plus a spread adjustment of 0.26161% + 2.959% payable quarterly in March, June, September and December, thereafter
E |  | 5.625% from issuance date, payable quarterly in March, June, September and December
F |  | 4.750% from issuance date, payable quarterly in March, June, September and December
G |  | 3.850% from issuance date, but excluding, September 15, 2025, payable semiannually in March and September; five-year treasury rate, reset every five years, + 3.576% payable semiannually in March and September, thereafter
Class of Treasury Stock | MetLife, Inc. announced that its Board of Directors authorized common stock repurchases as follows:
Announcement Date |  | Authorization Amount |  | Authorization Remaining at December 31, 2024 (1)
|  | (In millions)
May 1, 2024 |  | $ | 3,000 |  |  | $ | 1,925 |
May 25, 2023 |  | $ | 1,000 |  |  | $ | — |
May 3, 2023 |  | $ | 3,000 |  |  | $ | — |
May 4, 2022 |  | $ | 3,000 |  |  | $ | — |
_________________ (1)The Inflation Reduction Act, signed into law on August 16, 2022, imposes a one percent excise tax, net of any allowable offsets, on certain corporate stock buybacks made after December 31, 2022. The authorization remaining at December 31, 2024 does not reflect the applicable excise tax payable.
Dividends Declared [Table Text Block] | The per share and aggregate dividends declared for MetLife, Inc.’s preferred stock were as follows:
|  | Years Ended December 31,
|  | 2024 |  | 2023 |  | 2022
Series |  | Per Share |  | Aggregate |  | Per Share |  | Aggregate |  | Per Share |  | Aggregate
|  | (In millions, except per share data)
A |  | $ | 1.659 |  |  | $ | 39 |  |  | $ | 1.577 |  |  | $ | 37 |  |  | $ | 1.033 |  |  | $ | 24 |
D |  | $ | 58.750 |  |  | 29 |  |  | $ | 58.750 |  |  | 29 |  |  | $ | 58.750 |  |  | 29 |
E |  | $ | 1,406.252 |  |  | 45 |  |  | $ | 1,406.252 |  |  | 45 |  |  | $ | 1,406.252 |  |  | 45 |
F |  | $ | 1,187.500 |  |  | 48 |  |  | $ | 1,187.500 |  |  | 48 |  |  | $ | 1,187.500 |  |  | 48 |
G |  | $ | 38.500 |  |  | 39 |  |  | $ | 38.500 |  |  | 39 |  |  | $ | 38.500 |  |  | 39 |
Total |  |  |  | $ | 200 |  |  |  |  | $ | 198 |  |  |  |  | $ | 185 |

X
- Definition This is a table that shows the preferred stock dividend rates + References No definition available. + Details
Name: | met_PreferredStockDividendRatesTableTextBlock
Namespace Prefix: | met_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number of liability award units that were outstanding at the beginning and end of the year, and the number of liability award units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | met_ScheduleOfSharebasedCompensationLiabilityAwardUnitsActivityTableTextBlock
Namespace Prefix: | met_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information related to dividends declared, including paid and unpaid dividends. + References No definition available. + Details
Name: | us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss). + References No definition available. + Details
Name: | us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of statutory restrictions on the payment of dividends as prescribed by the National Association of Insurance Commissioners or state regulatory authorities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 944 -SubTopic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/944-505/tableOfContent + Details
Name: | us-gaap_ScheduleOfDividendPaymentRestrictionsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-4 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481142/505-10-45-2 Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-10 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8 Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1 Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6 Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7 + Details
Name: | us-gaap_ScheduleOfStockByClassTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1 + Details
Name: | us-gaap_ScheduleOfTreasuryStockByClassTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (i) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 944 -SubTopic 505 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477908/944-505-50-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 944 -SubTopic 505 -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477908/944-505-50-6 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 944 -SubTopic 505 -Section 55 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478420/944-505-55-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 944 -SubTopic 505 -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478420/944-505-55-1 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 944 -SubTopic 505 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477908/944-505-50-3 + Details
Name: | us-gaap_StatutoryAccountingPracticesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration